Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0180 | ||||
Gene Name | SLC25A20 | ||||
Protein Name | Carnitine/acylcarnitine translocase | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | CAC; CACT; Mitochondrial carnitine/acylcarnitine carrier protein; SLC25A20; Solute carrier family 25 member 20 | ||||
DT Family | Mitochondrial Carrier (MC) Family ; | ||||
Function | This transporter mediates the transport of acylcarnitines of different length across the mitochondrial inner membrane from the cytosol to the mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. | ||||
Endogenous Substrate(s) | Acyl carnitine | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-carnitine
|
Approved | Drug Info | Nutritional deficiency | 5B7Z | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 6 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Carnitine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
LysoPC(18:0) | EM Info | Unclear experiment used for identifying this EM | [2] | ||
LysoPC(20:1) | EM Info | Unclear experiment used for identifying this EM | [2] | ||
Palmitoylcarnitine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
Phytosphingosine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
Sphinganine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
References | |||||
1 | Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. Hum Mutat. 2004 Oct;24(4):312-20. | ||||
2 | Serum metabolomics reveals that arsenic exposure disrupted lipid and amino acid metabolism in rats: a step forward in understanding chronic arsenic toxicity. Metallomics. 2015 Mar;7(3):544-52. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.